Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted
- Resource Type
- Correspondence
- Source
- In
Respiratory Medicine November 2016 120:131-133 - Subject
- Language
- ISSN
- 0954-6111